Structural Heart

Together, Advancing TAVI

Advancing minimally invasive treatments through innovation, clinical evidence, training, and education. 

Boston Scientific offers innovative medical solutions for the treatment of structural heart (SH) disease in adults. Structural heart disease refers to cardiac defects which are either congenital in nature (birth defects), or abnormalities of the heart’s valves and vessels that can develop due to aging, injury or infection.

Boston Scientific specializes in minimally invasive catheter based technologies to treat SH disease. Our products are designed for Transcatheter Aortic Valve Implantation (TAVI) for the treatment of  aortic valve disease and Left Atrial Appendage Closure (LAAC) for stroke risk reduction in patients with atrial fibrillation.

Stay Updated

Sign up for major conferences, trial and technology pipeline updates, symposium invitations, and more.